Authors
Loading...
Anti-Podocalyxin monoclonal antibody humPcMab-60 demonstrates antitumor effects in pancreatic and colorectal cancer models, suggesting therapeutic potential.
Suzuki et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: